Norway · Delayed Price · Currency is NOK Navamedic ASA Company Description
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally.
Its product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics.
The company offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic and propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases, fat metabolism, renal, nutritional support, and ketogenic diet.
In addition, it provides consumer health products consisting of non-prescription drugs and health care products for erectile dysfunction, pain, gastro-related problems, and others primarily through pharmacies and drugstores; prescription medicines covering obesity, Parkinson’s disease, urology, and cardiology; and antibiotics.
It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004.
Navamedic ASA was founded in 2002 and is headquartered in Oslo, Norway.
| Country | Norway |
| Founded | 2002 |
| Industry | Medical Distribution |
| Sector | Healthcare |
| Employees | 38 |
| CEO | Kathrine E. Andreassen |
Contact Details
Address: Henrik Ibsens gate 100 Oslo, 0255 Norway | |
| Phone | 47 67 11 25 40 |
| Website | navamedic.com |
Stock Details
| Ticker Symbol | NAVA |
| Exchange | Oslo Børs |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | NOK |
| ISIN Number | NO0010205966 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Kathrine E. Gamborg Andreassen | Chief Executive Officer |
| Nils Ole Krekling | Chief Financial Officer |
| Alexander Lidmejer | Chief Operating Officer |
| Pal Zimmermann Vonen | Director of Group Accounting |
| Astrid J. Torgersen Bratvedt | Chief Scientific Officer |
| Annika Palo | Director of QA, Compliance and Sustainability |
| Ole Henrik Eriksen | Chief Business Development Officer |
| Nina Masvaer | Commercial Director of Nordics and Head of Rx |